Contract award · 9 Apr 2025

NP47825 Multiple Sclerosis Medicines: Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab

The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") awarded a contract to Biogen Idec Ltd, Merck Serono Limited…

Medical equipment & pharmaceuticalsScotland

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Value
£48,571,280 across 2 lots
Procedure
Open procedure
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date9 Apr 2025
  2. Published2 May 2025Published 23 days after the contract date

Description

Supply of glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumab to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

Lots in this award

LotSupplierValue
NP47825 Multiple Sclerosis Medicines: Glatiramer acetate solution for injection pre-filled syringes, interferon beta-1a, cladribine tablets, ozanimod capsules, and natalizumabBiogen Idec Ltd, Merck Serono Limited, Orifarm UK, Sandoz Ltd SME, Teva UK Limited +1 more£48m
NP47825 Multiple Sclerosis Medicines: Fingolimod capsules, teriflunomide tablets, and dimethyl fumarate capsulesRanbaxy UK Ltd SME, STADA UK - Thornton & Ross, Teva UK Limited£602k

About the suppliers

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

All contracts

More won by Biogen Idec Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview